GSK plc GSK
NYSE GSK
$47.83 -0.75 (-1.54%)
At close: Nov 19, 2026 · 4:00 PM EST

Gsk (GSK) Total Non-Current Liabilities (2009 - 2026)

Updated

Gsk (GSK) reported Total Non-Current Liabilities of -$43.16 billion for the quarter ended Sep 30, 2026, compared with -$32.59 billion a year earlier.

Analysis

Gsk (GSK) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends

As of Dec 31, 2025, Gsk posted Total Non-Current Liabilities of $32.01 billion, up 3.4% from the prior year.

  • Total Non-Current Liabilities has a five-year compound annual growth rate of -8.9% (years ended Dec 2020 to Dec 2025).
  • By year, Total Non-Current Liabilities came in at $30.97 billion in the year ended Dec 31, 2024 (-3.3%), $32.02 billion in the year ended Dec 31, 2023 (-2.5%), $32.84 billion in the year ended Dec 31, 2022 (-28.6%) and $46.02 billion in the year ended Dec 31, 2021 (-9.9%).
  • The figure for the quarter ended Sep 30, 2026 ranks as the lowest quarterly Total Non-Current Liabilities since the quarter ended Sep 30, 2021.
  • Per Business Quant data, the three quarters before the quarter ended Sep 30, 2026 came in at -$30.52 billion (quarter ended Jun 30, 2026), -$30.32 billion (quarter ended Mar 31, 2026) and $32.01 billion (quarter ended Dec 31, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 2.26 Mn
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 60.81 Bn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 102.65 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 117.60 Bn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 79.95 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 76.12 Bn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 36.05 Bn
9 Gsk 193.54 Bn 176.38 Bn - -43.16 Bn
10 Pfizer 156.44 Bn 103.79 Bn 12.56 Bn 96.04 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -43.16 Bn
Jun 30, 2026 -30.52 Bn
Mar 31, 2026 -30.32 Bn
Dec 31, 2025 32.01 Bn
Sep 30, 2025 -32.59 Bn
Jun 30, 2025 -33.65 Bn
Mar 31, 2025 -33.92 Bn
Dec 31, 2024 30.97 Bn
Sep 30, 2024 -30.96 Bn
Jun 30, 2024 -30.29 Bn
Mar 31, 2024 -32.12 Bn
Dec 31, 2023 32.02 Bn
Sep 30, 2023 -31.55 Bn
Jun 30, 2023 -31.78 Bn
Mar 31, 2023 -32.94 Bn
Dec 31, 2022 32.84 Bn
Sep 30, 2022 -34.23 Bn
Jun 30, 2022 -34.66 Bn
Mar 31, 2022 -17.27 Bn
Dec 31, 2021 46.02 Bn
API Access

Gsk Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=GSK&period=max&api_key=YOUR_API_KEY